ExploreWatchlistsPricing
  1. JP-listed companies
  2. TOWA PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Cash from investing

TOWA PHARMACEUTICAL CO.,LTD. (4553)

Market cap
¥223.3B
P/E ratio
12.1x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Mar 31, 2025-31,287-22.55%
Mar 31, 2024-40,394+33.38%
Mar 31, 2023-30,284-49.30%
Mar 31, 2022-59,729+556.36%
Mar 31, 2021-9,100-76.99%
Mar 31, 2020-39,541+890.01%
Mar 31, 2019-3,994-80.12%
Mar 31, 2018-20,093-9.52%
Mar 31, 2017-22,206+16.68%
Mar 31, 2016-19,032+131.25%
Mar 31, 2015-8,230

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat